Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Neurology | Family Medicine
Disease Category: Alzheimer's Disease
Location: United States, IL
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Efficacy and Safety Trial of Bapineuzumab (AAB-001) in Subjects with Mild to Moderate Alzheimer’s Disease who are Apolipoprotein E e4 Carriers
The purpose of this study is to test if bapineuzumab is effective and safe in treating Alzheimer’s Disease. This will be done during this study using tests that show how you are doing over time with memory, day to day activities, and other measures of brain function and disease.
Please contact Alexian Brothers for more information on participation.
Date Last Changed:
July 22, 2013
Alexian Brothers Hospital Network800 Biesterfield Road
Brock Building First FloorElk Grove Village, IL 60007Phone: 847-593-8553
Research Center Information: Alexian Brothers Hospital Network
If you would like to learn more about participating in this research study, please email the trial contact using the form below.
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.
Copyright © 1995-2015 CenterWatch.